Total Payments
$5,056
2024 Payments
$707.12
Companies
33
Transactions
233
Medicare Patients
11,426
Medicare Billing
$3.4M
Payment Breakdown by Category
Food & Beverage$4,210 (83.3%)
Travel$845.71 (16.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,210 | 228 | 83.3% |
| Travel and Lodging | $845.71 | 5 | 16.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Elekta, Inc. | $1,106 | 7 | $0 (2018) |
| ABBVIE INC. | $791.97 | 52 | $0 (2024) |
| Janssen Biotech, Inc. | $700.65 | 48 | $0 (2024) |
| Genentech USA, Inc. | $387.20 | 19 | $0 (2024) |
| MIMEDX Group, Inc. | $248.59 | 21 | $0 (2024) |
| GENZYME CORPORATION | $213.98 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $211.71 | 9 | $0 (2022) |
| LEO Pharma Inc. | $154.59 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $153.41 | 4 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $125.98 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $707.12 | 44 | MIMEDX Group, Inc. ($248.59) |
| 2023 | $270.87 | 13 | AbbVie Inc. ($54.27) |
| 2022 | $443.44 | 21 | ABBVIE INC. ($150.69) |
| 2021 | $518.60 | 31 | AbbVie Inc. ($204.53) |
| 2020 | $310.79 | 17 | Regeneron Healthcare Solutions, Inc. ($49.14) |
| 2019 | $460.70 | 26 | Janssen Biotech, Inc. ($82.30) |
| 2018 | $1,551 | 44 | Elekta, Inc. ($1,106) |
| 2017 | $793.88 | 37 | Genentech USA, Inc. ($176.01) |
All Payment Transactions
233 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $11.23 | General |
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $11.62 | General |
| 11/27/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $13.31 | General |
| 11/13/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $10.23 | General |
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $27.43 | General |
| 10/30/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $14.43 | General |
| 10/24/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $9.19 | General |
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Immunology | ||||||
| 10/17/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $9.90 | General |
| 10/11/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $9.17 | General |
| 10/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $11.83 | General |
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.24 | General |
| Category: Immunology | ||||||
| 09/30/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $8.50 | General |
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $7.81 | General |
| 08/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.97 | General |
| Category: Immunology | ||||||
| 08/27/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $6.71 | General |
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Immunology | ||||||
| 08/08/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $10.20 | General |
| 08/07/2024 | ProgenaCare Global, LLC | — | Food and Beverage | Cash or cash equivalent | $13.90 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 2,741 | 9,477 | $1.9M | $872,801 |
| 2022 | 38 | 2,522 | 5,207 | $1.4M | $781,041 |
| 2021 | 39 | 2,507 | 10,260 | $1.4M | $789,482 |
| 2020 | 41 | 3,656 | 11,373 | $2.3M | $951,777 |
Total Patients
11,426
Total Services
36,317
Medicare Billing
$3.4M
Procedure Codes
159
All Medicare Procedures & Services
159 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 372 | 452 | $493,469 | $202,897 | 41.1% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 238 | 342 | $228,965 | $121,557 | 53.1% |
| Q4186 | Epifix, per square centimeter | Office | 2023 | 16 | 814 | $174,960 | $95,799 | 54.8% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 93 | 117 | $120,798 | $57,155 | 47.3% |
| 14301 | Repair of wound by transferring skin, 30.1-60.0 sq cm | Office | 2023 | 56 | 56 | $98,874 | $51,915 | 52.5% |
| 14061 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 46 | 47 | $75,942 | $39,370 | 51.8% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 154 | 169 | $129,355 | $36,642 | 28.3% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 31 | 31 | $46,603 | $24,383 | 52.3% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 90 | 99 | $69,019 | $20,775 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 246 | 313 | $45,867 | $20,580 | 44.9% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 24 | 24 | $37,815 | $20,159 | 53.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 214 | 267 | $44,030 | $18,878 | 42.9% |
| 12034 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 7.6-12.5 cm | Office | 2023 | 62 | 70 | $38,233 | $18,021 | 47.1% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 37 | 41 | $26,183 | $13,959 | 53.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 50 | 57 | $27,889 | $12,080 | 43.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 59 | 78 | $21,364 | $11,242 | 52.6% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 17 | 17 | $20,991 | $10,444 | 49.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 186 | 254 | $27,483 | $9,673 | 35.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 89 | 203 | $16,844 | $8,772 | 52.1% |
| 15220 | Full thickness skin graft to scalp, arms, or legs, 20.0 sq cm or less | Office | 2023 | 12 | 13 | $16,085 | $8,282 | 51.5% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 48 | 52 | $22,970 | $6,745 | 29.4% |
| 14302 | Repair of wound by transferring skin, each additional 30.0 sq cm | Office | 2023 | 22 | 33 | $11,647 | $6,053 | 52.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 151 | 1,043 | $11,371 | $5,777 | 50.8% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 18 | 4,400 | $11,044 | $5,715 | 51.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 56 | 67 | $12,504 | $5,629 | 45.0% |
About Robert Willard
Robert Willard is a MOHS-Micrographic Surgery healthcare provider based in Doylestown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427097427.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Willard has received a total of $5,056 in payments from pharmaceutical and medical device companies, with $707.12 received in 2024. These payments were reported across 233 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,210).
As a Medicare-enrolled provider, Willard has provided services to 11,426 Medicare beneficiaries, totaling 36,317 services with total Medicare billing of $3.4M. Data is available for 4 years (2020–2023), covering 159 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Doylestown, PA
- Active Since 06/05/2006
- Last Updated 03/15/2012
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1427097427
Products in Payments
- Esteya (Device) $1,106
- Erivedge (Biological) $387.20
- SKYRIZI (Biological) $381.99
- TREMFYA (Drug) $369.59
- Humira (Biological) $232.06
- DUPIXENT (Biological) $189.60
- Tremfya (Drug) $168.14
- RINVOQ (Biological) $136.35
- COSENTYX (Biological) $132.89
- DUPIXENT (Drug) $130.91
- ILUMYA (Biological) $101.73
- STELARA (Biological) $100.07
- AMELUZ (Drug) $89.81
- Otezla (Drug) $86.12
- ENSTILAR (Drug) $80.15
- ADBRY (Biological) $74.44
- TALTZ (Drug) $72.53
- REMICADE (Biological) $62.85
- Kerecis Omega3 SurgiClose (Device) $54.71
- EPIDUO FORTE (Drug) $46.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.